is hers going to stop selling semaglutide Novo Nordisk CEO Maziar Mike Doustdar says it’s suing Hims & for making knock-offs of its obesity medicines, even as Hims scrapped plans sell a copycat version of the Wegovy pill. Read more The FDA announced plans to

One example is chicory inulin, a soluble fiber that resists digestion in the small intestine and reaches the colon, where it feeds Akkermansia and other probiotics

Composed of MB Core, which activates GLP-1 directly in L-cells, and MB Enhance, which optimizes the gut microbiome to amplify its production, the system helps users feel fuller longer, reduce cravings, and helps build healthier relationships with food

In summary, semaglutide has proven to be a pinnacle of GLP-1 drug development so far: highly efficacious for glycemic control, capable of inducing substantial weight loss, and demonstrating broad benefits (cardiovascular, renal, and beyond)

There is a reason these pills are cheap